La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Zhejiang Jingxin Pharmaceutical Bilan de santé
Santé financière contrôle des critères 6/6
Zhejiang Jingxin Pharmaceutical has a total shareholder equity of CN¥5.7B and total debt of CN¥473.0M, which brings its debt-to-equity ratio to 8.3%. Its total assets and total liabilities are CN¥8.5B and CN¥2.8B respectively. Zhejiang Jingxin Pharmaceutical's EBIT is CN¥713.5M making its interest coverage ratio -31.9. It has cash and short-term investments of CN¥1.3B.
Informations clés
8.3%
Ratio d'endettement
CN¥472.96m
Dette
| Ratio de couverture des intérêts | -31.9x |
| Argent liquide | CN¥1.27b |
| Fonds propres | CN¥5.69b |
| Total du passif | CN¥2.78b |
| Total des actifs | CN¥8.46b |
Mises à jour récentes de la santé financière
Analyse de la situation financière
Passif à court terme: 002020's short term assets (CN¥3.0B) exceed its short term liabilities (CN¥2.4B).
Passif à long terme: 002020's short term assets (CN¥3.0B) exceed its long term liabilities (CN¥366.5M).
Historique et analyse du ratio d'endettement
Niveau d'endettement: 002020 has more cash than its total debt.
Réduire la dette: 002020's debt to equity ratio has reduced from 10.1% to 8.3% over the past 5 years.
Couverture de la dette: 002020's debt is well covered by operating cash flow (181%).
Couverture des intérêts: 002020 earns more interest than it pays, so coverage of interest payments is not a concern.